These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 112310)

  • 1. Effect of thyrotropin releasing hormone instillation on canine senile cataracts.
    Abe M; Ono H
    Nihon Juigaku Zasshi; 1979 Jun; 41(3):325-31. PubMed ID: 112310
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of superoxide dismutase (orgotein) in medical treatment of canine cataract.
    Brainard J; Hanna C; Petursson G
    Arch Ophthalmol; 1982 Nov; 100(11):1832-4. PubMed ID: 7138354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orgotein and canine cataracts.
    Fischer CA
    J Am Vet Med Assoc; 1979 Aug; 175(3):248-50. PubMed ID: 500451
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oral antioxidants on the progression of canine senile cataracts: a retrospective study.
    Park S; Kang S; Yoo S; Park Y; Seo K
    J Vet Sci; 2022 May; 23(3):e43. PubMed ID: 35466599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment for acanthosis nigricans.
    Austin VH
    Mod Vet Pract; 1974 Mar; 55(3):202-7. PubMed ID: 4206815
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of a topical antioxidant formulation including N-acetyl carnosine on canine cataract: a preliminary study.
    Williams DL; Munday P
    Vet Ophthalmol; 2006; 9(5):311-6. PubMed ID: 16939459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes.
    Babizhayev MA; Deyev AI; Yermakova VN; Brikman IV; Bours J
    Drugs R D; 2004; 5(3):125-39. PubMed ID: 15139774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practitioner's experience with selenium-tocopherol in treatment of cataracts and nuclear sclerosis in the dog.
    Brooksby LO
    Vet Med Small Anim Clin; 1979 Mar; 74(3):301-2. PubMed ID: 255298
    [No Abstract]   [Full Text] [Related]  

  • 9. More on the medical "cure" for cataracts.
    Tiekert CG
    J Am Vet Med Assoc; 1986 Jun; 188(12):1364. PubMed ID: 3744960
    [No Abstract]   [Full Text] [Related]  

  • 10. More on treatment of cataracts.
    Munger RJ
    J Am Vet Med Assoc; 1986 Oct; 189(7):728, 730. PubMed ID: 3771333
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of diabetes mellitus regulation in dogs treated with ophthalmic preparations of prednisolone acetate versus diclofenac sodium.
    Rankin AJ; KuKanich KS; Schermerhorn T; Bello NM; Huey JA; Fentiman KE; Meekins JM
    Am J Vet Res; 2019 Dec; 80(12):1129-1135. PubMed ID: 31763946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary observations on orgotein treatment of canine cataract.
    Cobble RS; Lynd FT
    Mod Vet Pract; 1977 Dec; 58(12):1009-12. PubMed ID: 593253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of zinc citrate ascorbate for treatment of canine cataracts.
    MacMillan AD; Nelson DL; Munger RJ; Wolf ED; Scagliotti RH; Bellhorn RW; Shaw D; Schmidt G; Dice PF
    J Am Vet Med Assoc; 1989 Jun; 194(11):1581-2. PubMed ID: 2753777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thyrotropin releasing hormone instillation on keratitis in dairy cattle.
    Kato T; Ono H
    Nihon Juigaku Zasshi; 1981 Jun; 43(3):437-42. PubMed ID: 6798293
    [No Abstract]   [Full Text] [Related]  

  • 15. Superoxide dismutase drug study.
    Playter RF; Ellett EW; Brown CD; Lynd FT
    J Am Vet Med Assoc; 1980 Apr; 176(7):586, 598. PubMed ID: 7372529
    [No Abstract]   [Full Text] [Related]  

  • 16. Cataracts in Labrador Retriever and Jack Russell Terrier From the United Kingdom: A Two-Year Retrospective Study.
    Guerra R; Cabeças R; Diaz J; Knott T; Freitas I; Vilhena H; Duarte S
    Top Companion Anim Med; 2018 Dec; 33(4):109-113. PubMed ID: 30502859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin releasing hormone and canine circulatory shock.
    Teba L; Dedhia HV; Schiebel F
    Crit Care Med; 1988 May; 16(5):568-9. PubMed ID: 3129237
    [No Abstract]   [Full Text] [Related]  

  • 18. Aqueous humor fibrinolytic activity in dogs with cataracts.
    Escanilla N; Leiva M; Monreal L; Ríos J; Peña T
    Vet Ophthalmol; 2013 Nov; 16(6):409-15. PubMed ID: 23240635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone and dementia.
    Sunderland T; Mellow AM; Gross M; Cohen RM; Tariot PN; Newhouse PA; Murphy DL
    Am J Psychiatry; 1986 Oct; 143(10):1318. PubMed ID: 3094388
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.
    van der Vis-Melsen MJ; Weiner JD
    Lancet; 1972 Dec; 2(7792):1415. PubMed ID: 4118700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.